Nielsen Mette Ødegaard, Rostrup Egill, Broberg Brian Villumsen, Wulff Sanne, Glenthøj Birte
1 Center for Neuropsychiatric Schizophrenia Research (CNSR) & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Copenhagen University Hospital, Mental Health Centre Glostrup, Denmark.
2 Functional Imaging Unit, Department of Clinical Physiology and Nuclear Medicine Rigshospitalet, Glostrup, Denmark.
Clin EEG Neurosci. 2018 Jan;49(1):36-45. doi: 10.1177/1550059417744120. Epub 2017 Nov 17.
Negative symptoms (NS) are a central part of the symptomatology of schizophrenia, which is highly correlated to the functional outcome. Disturbances of the brain reward system are suggested to be central in the pathogenesis of NS by decreasing motivation and hedonic experiences. In this study, we compared reward-related brain activity in patients improving and not improving in NS after treatment with amisulpride.
Thirty-nine antipsychotic-naive patients and 49 healthy controls completed functional magnetic resonance imaging with a modified monetary incentive delay task. Psychopathology of the patients was characterised with Positive and Negative Syndrome Scale (PANSS), and they were treated with individual doses of amisulpride (mean 271 mg) for 6 weeks, after which the examinations were repeated.
Patients improved on positive, general, and total PANSS score after treatment ( P < .001). Fourteen patients had ≥20% improvement of NS, whereas 25 patients improved <20%. At baseline, one-way analysis of variance showed group difference bilaterally in the caudate nucleus and in the right nucleus accumbens (all P < .002), which was caused by decreased reward anticipation activity in the nonimproving patients compared to healthy controls. There was a significant group × time interaction, with the healthy controls and the improvers decreasing and the nonimprovers increasing in reward anticipation activity after treatment, most pronounced in the left caudate nucleus ( P = .001).
Patients improving in NS score had a less aberrant reward system at baseline, but reward related activity was reduced over time. Patients not improving in NS showed decreased striatal reward-activity at baseline, which improved over time. Whether this is associated with alteration in working memory and reward learning or with pronounced symptoms within specific domains of NS may be addressed in future studies.
阴性症状是精神分裂症症状学的核心部分,与功能结局高度相关。大脑奖赏系统功能障碍被认为是阴性症状发病机制的核心,因为它会降低动机和享乐体验。在本研究中,我们比较了使用氨磺必利治疗后阴性症状改善和未改善的患者与奖赏相关的脑活动。
39例未使用过抗精神病药物的患者和49名健康对照者完成了一项使用改良金钱激励延迟任务的功能磁共振成像检查。使用阳性和阴性症状量表(PANSS)对患者的精神病理学进行评估,患者接受个体化剂量的氨磺必利(平均271mg)治疗6周,之后重复进行检查。
治疗后患者的阳性、一般和PANSS总分均有改善(P <.001)。14例患者阴性症状改善≥20%,而25例患者改善<20%。在基线时,单因素方差分析显示双侧尾状核和右侧伏隔核存在组间差异(均P <.002),这是由于未改善的患者与健康对照者相比,奖赏预期活动降低所致。存在显著的组×时间交互作用,治疗后健康对照者和改善者的奖赏预期活动降低,而未改善者增加,在左侧尾状核最为明显(P =.001)。
阴性症状评分改善的患者在基线时奖赏系统异常程度较轻,但奖赏相关活动随时间减少。阴性症状未改善的患者在基线时纹状体奖赏活动降低,但随时间有所改善。这是否与工作记忆和奖赏学习的改变有关,或者与阴性症状特定领域内的明显症状有关,可能需要在未来的研究中加以探讨。